A patient with essential thrombocytosis and multiple sclerosis.
We report on a patient with a 5-year history of essential thrombocytosis (ET) who developed multiple sclerosis (MS) during the last 5 months. The patient was treated for MS with interferon-beta (IFN-beta), which also had a beneficial effect on the ET. We describe the patient's history and the beneficial effect of IFN-beta administration in reducing the number of platelets. We also discuss the possible link between the pathogenesis of ET and MS.
Tsiara
SN
Hematology Unit and Department of Neurology, University of Ioannina Medical School, 47 G. Papandreou, PO Box 37, GR-45002, Ioannina, Greece
Christou
L
Panteli
K
Anastasopoulos
D
Bourantas
KL